Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 27 2025

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-feb-27-2025-4

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases